With mTOR pathway antibodies, anti‐pS6 (ser235/236 and ser240/244), minimal labelling of VC was observed across all cases; occasional dot‐like positivity in the cytoplasm was noted in some VC, in contrast to the intense labelling of scattered pyramidal cells in the overlying cortex (Figure 4L; insets) and the dysmorphic neurons of the ganglioglioma component of Case 8. Here, MTOR is linked to ganglioglioma.